BPC 157: Experimental Peptide Creates Risk for Athletes The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and In the era of Make America Healthy Again, the popularity of peptidesshort chains of amino acids that often act as signalling molecules in the bodyhas risen sharply. Many compounding pharmacies, which produce FDA Compliance for Peptide Therapy and BPC 157 Holt Law